| |
|
The efficacy of glyconutrients has been established
by the world's leading scientists and researchers as the key to
proper cellular communication and proper cell function. Many business
analysts and healthcare professionals believe this medical breakthrough
in glycoscience will lead to glyconutrients becoming a household
word within the next three years.
 |
- June 30, 2006
Toward An Early Diagnostic Test For Ovarian Cancer |
In an advance toward eventual
development of a much-needed early diagnostic test for ovarian
cancer, scientists have identified at least 15 biomarkers
for the disease that are present in cancer patients but absent
in healthy individuals.
…. biomarkers -- which could become the basis of a
test -- with an exciting new technology spawned by the human
genome project. Called glycomics, it focuses on the structure
and function of chains of sugars or "oligosaccharides"
that have key functions in the body. |
 |
- August 2, 2004. Growing evidence
suggests that changes in the patterns of glycans may be biomarkers
for disease states, such as cancer or autoimmune disease. Israeli
biotech Glycominds, for instance, has discovered a biomarker
for multiple sclerosis (MS), an autoimmune disease. According
to the company, this biomarker will allow faster, more cost-effective
diagnosis of MS, including more rapid classification of the
disease's severity in individual patients. |
| Vernon Reinhold, a longtime
researcher in the field and who is credited with coining the
term glycome, describes the future succinctly: "Now that
glycosylation has taken hold as really important in biological
function, it will start opening the doors into what these structures
do." That future should provide the sweet smell of success
for glycomics researchers. |
 |
-
Nutrition: How Sweet It Is by Hara Estroff Marano. Publication
Date: Jun 8, 2004
"Over 200 sugar compounds, technically
known as saccharides, occur naturally in plants. And eight
of them, known as glyconutrients, have been identified as
essential to optimal human health. |
On the frontiers of medicine,
researchers are testing therapeutic applications of various
glyconutrients missing from our everyday diet. Preliminary
clinical trials have shown that supplementation with glyconutrients
may enhance memory, support a variety of higher brain functions,
and help curb the stress response. They also reduce allergies
and allay symptoms of arthritis, diabetes, lupus and kidney
disease (in animals). Several labs and are looking into ways
to use sugar compounds to improve the medicines used to fight
anemia, HIV and cancer."
Click
Here to read the whole article |
 |
- In the February 2003 edition of
Technology Review, the Massachusetts Institute of Technology
profiled the science of glycomics as a new technology that
“…could have an impact on health problems ranging
from rheumatoid arthritis to the spread of cancer cells.”
Glycomics is the study of sugars and includes glycobiology-the
study of the effects of sugars on living organisms. |
“If you don’t
have glycosylation, you don’t have life.”
“The medical potential…is
absolutely enormous.” –MIT
Technology Review |
| 
|
- July/August 2002.
Feature article entitled "Glyconutrients
Could Offer Novel Approach to Asthma." |
 |
- Medicine, July, 2002.
"Sweet Medicine: Building Better Drugs from Sugars."
Sugars play critical roles in many cellular functions and
in disease. Study of those activities lags behind research
into genes and proteins but is beginning to heat up. The discoveries
promise to yield a new generation of drug therapies. |
 |
- June 2002.
M.D. News, a national publication with
regionalized editions in 40 major medical markets in the U.S.
This 3-page article covers the science of sugars and reviews
specific topics such as successes with fibromyalgia, toxic
shock and diabetes. |
 |
- Jan. 22, 2002.
"Changing Cancer Cells' 'Surface
Sugars' Can Inhibit Tumor Growth."
"The key to halting cancer
cells may lie in their sugary coats, scientists say.
|
Carbohydrate
molecules surround all cells and help them to identify and
interact with one another. Now new research, published
today in the Proceedings of the National Academy of Sciences,
indicates that altering some of the surface sugars associated
with cancer cells can control tumor growth. The findings suggest
that the sugars could one day serve as targets for new anti-cancer
therapies." |
 |
- October 2001. "Sugars Could
be Biology's Next Sweet Spot." |
| Technology Review promotes
the understanding of emerging technologies and their impact
on business and society. In this issue the magazine emphasizes
the next field of biology is waiting to break out: glycomics.
This emerging discipline seeks move sugars and carbohydrates
into the mainstream of biomedical research and drug discovery. |
 |
- Special Issue, March 23, 2001.
This premier journal for researchers
and scientists recently dedicated an entire issue to educating
the science and medical community about Glyconutrients, Glycobiology
and Glycoscience. |
 |
- Glycosciences, Issue 161/1-April 1998 International
Journal of Anatomy, Embryology and Cell Biology. "Glycosylation
is the most common form of protein and lipid modification
but its biological significance has long been underestimated.
The last decade, however, has witnessed the rapid emergence
of the concept of the sugar code of biological information.
Monosaccharides represent an alphabet of biological information
similar to amino acids and nucleic acids but with unsurpassed
coding capacity." |
 |
- a medical textbook that has been educating healthcare professionals
about Glyconutrients and their role in health and healing
since 1996. From a clinical perspective, one class of nutrients
absolutely necessary for optimal cellular communication and
which is essentially missing from our food supply is glyconutrients.
|
These are necessary carbohydrates
(monosaccharides) that according to the 1996 edition of Harper's
Biochemistry, only 2 or 3 of the necessary 8 are commonly
found in our diet. These monosaccharides provide the necessary
building blocks that enable the cells of our body to communicate
effectively. |
 |
- (PDR) for Nonprescription Drugs and
Dietary Supplements is used by 99% of all doctors and healthcare
professionals before recommending solutions to their patients.
Glyconutrients are listed for compromised immune systems. |
 |
- featured a story that talked about the power of the same substances
in our product line to "kill and necrose cancer in the
human cell" |
 |
- “Sweetness and Might: Awesome power
of the glycome” - |
| "This is going to be
the future," declares biochemist Gerald Hart of Johns Hopkins
University in Baltimore. "We won't understand immunology,
neurology, developmental biology or disease until we get a handle
on Glycobiology." |
Products
|
|
